ストックスクリーナーアプリを入手
13.75
9.35%
1.235
前日終値:
$12.52
開ける：
$12.42
24時間の取引高:
265.43K
Relative Volume:
1.55
時価総額：
$633.48M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+6.75%
1か月 パフォーマンス:
+42.55%
6か月 パフォーマンス:
+98.62%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$12.10
$13.91
1週間の範囲:
$11.32
$13.91
52週間の値動き範囲:
$6.565
$13.91
Jade Biosciences Inc Stock (JBIO) Company Profile
JBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
13.77 | 570.45M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.15 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
719.35 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.98 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
897.23 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.41 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-09 | 開始されました | BTIG Research | Buy |
| 2025-07-14 | 開始されました | Jefferies | Buy |
| 2025-06-16 | アップグレード | Guggenheim | Neutral → Buy |
| 2025-05-07 | 開始されました | Wedbush | Outperform |
| 2025-05-05 | 開始されました | Stifel | Buy |
| 2025-05-02 | 開始されました | TD Cowen | Buy |
| 2024-06-18 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-06-18 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-06-18 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-06-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-06-17 | ダウングレード | Wedbush | Outperform → Neutral |
| 2024-03-25 | 再開されました | Jefferies | Buy |
| 2023-12-08 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2022-12-06 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-09-19 | 再開されました | Wedbush | Outperform |
| 2022-08-16 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-02-11 | 開始されました | BTIG Research | Buy |
| 2021-07-26 | 開始されました | Cowen | Outperform |
| 2021-07-26 | 開始されました | Evercore ISI | Outperform |
| 2021-07-26 | 開始されました | Jefferies | Buy |
| 2021-07-26 | 開始されました | Wedbush | Outperform |
すべてを表示
Jade Biosciences Inc (JBIO) 最新ニュース
Does Jade Biosciences, Inc. (JBIO) Have the Potential to Rally 65% as Wall Street Analysts Expect? - Zacks Investment Research
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives $19.75 Average Price Target from Brokerages - Defense World
Is Jade Biosciences Inc. stock resilient to inflationWeekly Trade Analysis & Daily Growth Stock Investment Tips - BỘ NỘI VỤ
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Jade Biosciences Inc (JBIO) looking to reclaim success with recent performance - Setenews
Clear Street Initiates Coverage of Jade Biosciences (JBIO) with Buy Recommendation - Nasdaq
Clear Street initiates Jade Biosciences stock with Buy rating on IgAN therapy - Investing.com Canada
How Jade Biosciences Inc. stock performs after earnings2025 Top Gainers & High Win Rate Trade Tips - newser.com
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock - MSN
Guggenheim Maintains Jade Biosciences (JBIO) Buy Recommendation - MSN
Detecting support and resistance levels for Jade Biosciences Inc.Short Setup & Weekly High Conviction Trade Ideas - newser.com
How Jade Biosciences Inc. stock performs during Fed tightening cyclesJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Is Jade Biosciences Inc. forming a reversal patternJuly 2025 Analyst Calls & Proven Capital Preservation Methods - newser.com
Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - Zacks Investment Research
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday - Benzinga
Does Jade Biosciences Inc. fit your quant trading modelWeekly Gains Report & Reliable Volume Spike Trade Alerts - newser.com
Jade Biosciences Advances Autoimmune Therapies - MSN
Multi asset correlation models including Jade Biosciences Inc.Quarterly Trade Review & Reliable Entry Point Alerts - newser.com
Jade Biosciences files for offering of up to 16.1 million shares of common stock by the selling stockholdersSEC filing - MarketScreener
Wedbush Adjusts Price Target on Jade Biosciences to $19 From $18, Maintains Outperform Rating - MarketScreener
JBIO: Strong pipeline progress and financing extend cash runway into 2028 despite higher net loss - TradingView
Jade Biosciences Reports Q3 2025 Financial Results - TipRanks
Jade Biosciences, Inc. SEC 10-Q Report - TradingView
How Jade Biosciences Inc. stock reacts to inflationary pressuresSell Signal & Daily Volume Surge Trade Alerts - newser.com
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Jade Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Will Jade Biosciences Inc. see short term momentumWeekly Trend Summary & Safe Capital Growth Plans - newser.com
Jade Biosciences (JBIO) Price Target Increased by 13.43% to 19.38 - MSN
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025 - The Manila Times
Jade Biosciences, Inc. Presents New Data Demonstrating A Favorable Preclinical Safety Profile of Jade101 and a Translational Analysis of April Mediated Biomarker Responses At the American Society of Nephrology Kidney Week 2025 - MarketScreener
Jade Biosciences (NASDAQ: JBIO) shows 55–68% IgA reductions in NHPs; JADE101 safety data - Stock Titan
Jade Biosciences Presents New Data Demonstrating a - GlobeNewswire
Jade Biosciences Inc expected to post a loss of 67 cents a shareEarnings Preview - TradingView
Jade Biosciences Inc (JBIO) 財務データ
Jade Biosciences Inc (JBIO) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.39%
1.05%
大文字化:
|
ボリューム (24 時間):